A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma/ocular hypertension.
Indian J Ophthalmol
; 2014 Dec ; 62 (12): 1136-1140
Article
in En
| IMSEAR
| ID: sea-155817
Full text:
1
Index:
IMSEAR
Type of study:
Clinical_trials
/
Health_economic_evaluation
Language:
En
Journal:
Indian J Ophthalmol
Year:
2014
Type:
Article